-
Sidra Medicine Launches New Phase in Pediatric Cancer Research 15 November 2023, Doha, Qatar – Sidra Medicine (a QF entity) has initiated a new phase in cancer care, with its pediatric cancer research program, to advance the cutting-edge diagnosis, early detectio… Continue Reading.....
-
PMFG 2023: Day 4 - Final Day Updates Sidra Medicine Launches Good Manufacturing Practices (GMP) Facility Focus on Precision Medicine in Pediatric Cancers 14 November 2023, Doha, Qatar – Sidra Medicine (a QF entity) today announ… Continue Reading.....
-
PMFG 2023: Day Three Highlights Launch of new genetic study to enable better fertility treatment and pregnancy outcomes Global advancements in pediatric precision medicine - from genomics to disease modeling 13 November 20… Continue Reading.....